Remdesivir becomes first FDA-approved COVID-19 treatment

(By Katie Adams for Becker’s Hospital Review)

The FDA on Oct. 22 granted approval to remdesivir, which Gilead sells under the brand name Veklury, as a COVID-19 treatment for hospitalized patients aged 12 years and older.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org